Pranay Patel, MD
Otolaryngology/Facial Plastic Surgery · Lakeland, FLNPI 1467423673
Payments from drug & device makers
What this record shows
Intersect ENT, Inc. accounts for 66.1% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $3,237 and has fallen 89.2% since, to $349 in 2025.
Across 89 payments — averaging $50.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$3K
- Aerin Medical Inc.$199
- Medtronic$132
- Sanofi$127
- Genentech USA, Inc.$119
- AbbVie$119
- plus $827 from 17 others
What the payments were for
- Travel & lodging$2,09447%
- Food & beverage$2,40653%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 15 | $2,976 |
| Aerin Medical Inc. | 13 | $199 |
| Medtronic | 6 | $132 |
| Sanofi | 4 | $127 |
| Genentech USA, Inc. | 9 | $119 |
| AbbVie(2 entities) | 5 | $119 |
| Acclarent, Inc | 4 | $95 |
| Stryker | 3 | $94 |
| Integra Lifesciences Corporation | 3 | $86 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| Neurent Medical Limited | 4 | $75 |
| GSK | 3 | $73 |
| Phathom Pharmaceuticals, Inc. | 3 | $59 |
| Hikma Pharmaceuticals USA | 3 | $49 |
| Inspire Medical Systems, Inc. | 2 | $39 |
| Galderma Laboratories, L.p. | 2 | $29 |
| Optinose US, Inc. | 1 | $28 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Phadia US Inc. | 1 | $24 |
| Aclaris Therapeutics, Inc. | 1 | $20 |
| Amgen | 1 | $18 |
| Novartis | 1 | $17 |
| Checkpoint Surgical, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,499 in reported general payments places this provider in the 70th percentile of 48 otolaryngology/facial plastic surgery providers in Florida.
See all otolaryngology/facial plastic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 70 | $2,020 |
| Fluticasone Propionate | 142 | $1,823 |
| Pantoprazole Sodium | 158 | $1,643 |
| Fluocinolone Acetonide Oil | 29 | $1,629 |
| Cefadroxil | 340 | $1,564 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 14 | $1,465 |
| Montelukast Sodium | 78 | $1,253 |
| SynthroidLevothyroxine Sodium | 13 | $798 |
| Triamcinolone Acetonide | 19 | $653 |
| Mometasone Furoate | 29 | $518 |
| Azelastine Hcl | 23 | $482 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 34 | $464 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 58 | $407 |
| Omeprazole | 14 | $380 |
| Cefdinir | 15 | $366 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $119 | $79813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 48 otolaryngology/facial plastic surgery providers in Florida.
Other otolaryngology/facial plastic surgery in Lakeland
- Raam LakhaniLakeland$3K
- Jeffrey PaffrathLakeland$646
- Jeffery MagnusonCelebration$37K
- Ryan GeggSanta Rosa Beach$11K
- Paul di PasqualeWesley Chapel$10K
- David GerthMiami$9K
- Michael SeidmanCelebration$9K
- Maria ComptonPort Charlotte$7K
- David CarlsonJacksonville$6K
- Janet LeeTampa$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.